Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.

Lysosomal permeabilization is a key feature of hepatocyte lipotoxicity, yet the mechanisms mediating this critical cellular event are unclear. This study examined the mechanisms involved in free fatty acid (FFA)-induced lysosomal permeabilization and the role of Bax, a Bcl-2 family member, in this event. Exposure of liver cells to palmitate induced Bax activation and translocation to lysosomes. Studies to suppress Bax activation either by pharmacological approaches or small interfering-RNA-mediated inhibition of Bax expression showed that lysosomal permeabilization is Bax dependent. In addition, palmitate treatment resulted in a significant decrease in Bcl-X(L), a Bax antagonist. Moreover, forced Bcl-X(L) expression blocked lysosomal permeabilization. Lysosomal permeabilization by FFA was ceramide and caspase independent. Finally, paradigms that inhibit lysosomal permeabilization also reduced apoptosis. In conclusion, these data strongly support a regulatory role for Bax in FFA-mediated lysosomal permeabilization and subsequent cell death.

[1]  J. Horton,et al.  Molecular mediators of hepatic steatosis and liver injury. , 2004, The Journal of clinical investigation.

[2]  G. Gores,et al.  O0040 FREE FATTY ACIDS PROMOTE HEPATIC LIPOTOXICITY BY STIMULATING TNF‐ALPHA EXPRESSION VIA A LYSOSOMAL PATHWAY , 2004, Journal of Pediatric Gastroenterology and Nutrition.

[3]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[4]  G. Gores,et al.  Free fatty acids promote hepatic lipotoxicity by stimulating TNF‐α expression via a lysosomal pathway , 2004 .

[5]  C. Casiano,et al.  Palmitic and stearic fatty acids induce caspase‐dependent and ‐independent cell death in nerve growth factor differentiated PC12 cells , 2003, Journal of neurochemistry.

[6]  G. Marchesini,et al.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.

[7]  G. Gores,et al.  Apoptosis in alcoholic and nonalcoholic steatohepatitis. , 2005, Frontiers in bioscience : a journal and virtual library.

[8]  M. Sawada,et al.  Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70 , 2003, Nature Cell Biology.

[9]  G. Gores,et al.  Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. , 2003, Gastroenterology.

[10]  G. Gores,et al.  Tumor necrosis factor-α-associated lysosomal permeabilization is cathepsin B dependent , 2002 .

[11]  P. Angulo,et al.  Nonalcoholic fatty liver disease. , 2002, Revista de gastroenterologia de Mexico.

[12]  J. Friedman,et al.  Obesity in the new millennium , 2000, Nature.

[13]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.

[14]  J. Schaffer,et al.  Lipotoxicity: when tissues overeat , 2003, Current opinion in lipidology.

[15]  R. Unger,et al.  Role of nitric oxide in obesity-induced beta cell disease. , 1997, The Journal of clinical investigation.

[16]  R. Unger,et al.  Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Unger,et al.  Fatty acid-induced β cell apoptosis: A link between obesity and diabetes , 1998 .

[18]  G. Gores,et al.  Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. , 2003, Journal of hepatology.

[19]  S. Sanderson,et al.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.

[20]  G. Gores,et al.  Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes. , 1997, Gastroenterology.

[21]  A. Feldstein,et al.  Nonalcoholic fatty liver disease in the pediatric population: a review , 2005, Current opinion in pediatrics.

[22]  J. Schaffer,et al.  Mechanisms of lipoapoptosis: implications for human heart disease. , 2002, Trends in cardiovascular medicine.

[23]  R. Unger,et al.  Lipotoxic diseases. , 2002, Annual review of medicine.

[24]  Z. Younossi,et al.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.

[25]  G. Gores,et al.  TNF-α-mediated lysosomal permeabilization is FAN and caspase 8/Bid dependent , 2004 .

[26]  M. Mcdaniel,et al.  cAMP Dose-dependently Prevents Palmitate-induced Apoptosis by Both Protein Kinase A- and cAMP-Guanine Nucleotide Exchange Factor-dependent Pathways in β-Cells* , 2004, Journal of Biological Chemistry.

[27]  G. Gores,et al.  Lysosomes in cell death , 2004, Oncogene.

[28]  L. Orci,et al.  Lipotoxic heart disease in obese rats: implications for human obesity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Y. Hsu,et al.  Bax in Murine Thymus Is a Soluble Monomeric Protein That Displays Differential Detergent-induced Conformations* , 1998, The Journal of Biological Chemistry.

[30]  Keith D. Lindor,et al.  Nutritional and Metabolic Considerations in the Etiology of Nonalcoholic Steatohepatitis , 2001, Digestive Diseases and Sciences.

[31]  S. Cory,et al.  The Bcl2 family: regulators of the cellular life-or-death switch , 2002, Nature Reviews Cancer.

[32]  R. Unger.  Lipid overload and overflow: metabolic trauma and the metabolic syndrome , 2003, Trends in Endocrinology & Metabolism.

[33]  M. Sawada,et al.  Bax-inhibiting peptide derived from mouse and rat Ku70. , 2004, Biochemical and biophysical research communications.

[34]  C. Day,et al.  Non‐alcoholic steatohepatitis: Definitions and pathogenesis , 2002, Journal of gastroenterology and hepatology.

[35]  W. Schneider-Brachert,et al.  Cathepsin D targeted by acid sphingomyelinase‐derived ceramide , 1999, The EMBO journal.

[36]  Robert V Farese,et al.  Triglyceride accumulation protects against fatty acid-induced lipotoxicity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Simonson,et al.  Saturated free fatty acids and apoptosis in microvascular mesangial cells: palmitate activates pro-apoptotic signaling involving caspase 9 and mitochondrial release of endonuclease G , 2005, Cardiovascular diabetology.

[38]  B. Neuschwander‐Tetri,et al.  Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis , 2020, Clinical Gastroenterology and Hepatology.

[39]  E. Brunt,et al.  Pathology of steatohepatitis. , 2002, Best practice & research. Clinical gastroenterology.

[40]  Y. Hsu,et al.  Nonionic Detergents Induce Dimerization among Members of the Bcl-2 Family* , 1997, The Journal of Biological Chemistry.

[41]  A. Diehl.  Fatty liver, hypertension, and the metabolic syndrome , 2004, Gut.